Expression profile of diagnostic genes in oral submucous fibrosis

被引:2
作者
Srivastava, Prerna [1 ]
Rai, Arpita [2 ]
Kumar, Manish [1 ]
机构
[1] Birla Inst Technol, Dept Bioengn & Biotechnol, Ranchi 835215, Jharkhand, India
[2] Rajendra Inst Med Sci, Dent Inst, Ranchi 834009, India
关键词
OSMF; Saliva; Tissue; Diagnostic genes; Histopathology and RT-qPCR; SQUAMOUS-CELL CARCINOMA; ARECA NUT; CANCER; TROPOMYOSIN; SIGNATURE; MYOFIBROBLASTS; TISSUE; STROMA; SALIVA;
D O I
10.1016/j.prp.2024.155416
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Oral Submucous Fibrosis (OSMF) is a chronic precancerous disorder of the oral mucosa caused by chewing of areca nut and its other variants. Chewing of areca nuts leads to dysregulated expression of specific genes, leading to various premalignant or malignant disorders. This study aimed to determine the differential expression of the diagnostic genes (MYH6, TNNT3, MYL1, and TPM2) in healthy controls and OSMF patients using saliva and tissue samples, determining the histopathological grade of the clinical samples. A total of 20 patients were included in the study and were divided into two groups: Group I consisted of 10 healthy patients (control group) and Group II consisted of 10 OSMF patients. Unstimulated whole saliva samples were collected from both groups, and the tissue samples were divided into two parts: one for RT-qPCR analysis and the other for histopathological assay. The expression profile of genes concerning OSMF saliva and tissue samples was significantly upregulated compared to the healthy control, and all the clinical samples of the study were categorized into histopathological grade 1. The findings of this study concluded that these genes can be referred to as diagnostic genes for OSMF in early and very early clinical samples, and saliva can be used as a promising diagnostic tool for early OSMF studies.
引用
收藏
页数:6
相关论文
共 50 条
[41]   Malignant transformation of oral submucous fibrosis: A systematic review and meta-analysis [J].
Kujan, Omar ;
Mello, Fernanda Weber ;
Warnakulasuriya, Saman .
ORAL DISEASES, 2021, 27 (08) :1936-1946
[42]   Oral submucous fibrosis. A review [J].
Cox, SC ;
Walker, DM .
AUSTRALIAN DENTAL JOURNAL, 1996, 41 (05) :294-299
[43]   Management of oral submucous fibrosis: An overview [J].
Angadi P.V. ;
Rao S. .
Oral and Maxillofacial Surgery, 2010, 14 (3) :133-142
[44]   Dental Fusion with Oral Submucous Fibrosis [J].
Sudarshan, Ramachandran .
CUKUROVA MEDICAL JOURNAL, 2013, 38 (02) :308-310
[45]   Alterations in Serum Lipid Profile in Oral Cancer and Oral Submucous Fibrosis Patients: A Clinicopathological Study. [J].
Sangle, Varsha Ajit ;
Chaware, Smita ;
Male, Vijayalaxmi ;
Biradar, Ashwini ;
Ugale, Gauri ;
Chaudhary, Mayur .
ORAL & MAXILLOFACIAL PATHOLOGY JOURNAL, 2023, 14 (02) :171-175
[46]   T cell subset-an overview in oral submucous fibrosis and oral squamous cell carcinoma in background of oral submucous fibrosis [J].
Yadahalli, Roopa ;
Sarode, Gargi S. ;
Sarode, Sachin C. .
FRONTIERS OF ORAL AND MAXILLOFACIAL MEDICINE, 2024, 6
[47]   Proinflammatory cytokine levels in oral lichen planus, oral leukoplakia, and oral submucous fibrosis [J].
Kaur, Jasdeep ;
Jacobs, Reinhilde .
JOURNAL OF THE KOREAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS, 2015, 41 (04) :171-175
[48]   Salivary transforming growth factor beta in oral submucous fibrosis: A diagnostic and predictive marker [J].
Rai, Arpita ;
Parveen, Shama ;
Shree, Priya ;
Ahmed, Tanveer ;
Ali, Sher ;
Kaur, Mandeep ;
Sircar, Keya ;
Sybil, Debora ;
Chandra, Akhilesh .
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2024, 20 (01) :275-280
[49]   Alterations in expression of retinoid receptor β and p53 in oral submucous fibrosis [J].
Kaur, J ;
Chakravarti, N ;
Mathur, M ;
Srivastava, A ;
Ralhan, R .
ORAL DISEASES, 2004, 10 (04) :201-206
[50]   Letter to Editor: 'Lactate dehydrogenase as a biomarker in oral cancer and oral submucous fibrosis' [J].
Moosavi, Mahdieh-Sadat ;
Keykha, Elham ;
Fathi, Yaser .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2016, 45 (09) :721-721